Lindbrook Capital’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AXGN
FLAM
ACH
SCM
DCM
Lindbrook Capital's AXGN Position: Q1 2025 in Review
Lindbrook Capital increased its Axogen (AXGN) stake by 69% in Q1 2025, buying an estimated $794 and bringing the position to 108 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2286.
Lindbrook Capital first reported a position in AXGN in Q2 2022 and has held it in 8 quarters since. The position peaked at $2K in Q3 2022. 181 funds tracked by Wall St. Rank hold AXGN as of Q1 2025.
- Lindbrook Capital held 108 shares of Axogen worth $2K as of Q1 2025.
- Lindbrook Capital bought 44 Axogen shares in Q1 2025, an estimated $794.
- Axogen made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2286 holding.
- Lindbrook Capital first reported a position in Axogen in Q2 2022 and has held it in 8 quarters since.
- Lindbrook Capital's Axogen position peaked at $2K in Q3 2022.
- 181 funds tracked by Wall St. Rank held Axogen as of Q1 2025.
Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.